Principal Financial Group Inc. Purchases 4,214 Shares of Teleflex Incorporated $TFX

Principal Financial Group Inc. increased its position in Teleflex Incorporated (NYSE:TFX) by 2.0% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 214,193 shares of the medical technology company’s stock after acquiring an additional 4,214 shares during the period. Principal Financial Group Inc. owned about 0.48% of Teleflex worth $25,620,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in TFX. AQR Capital Management LLC increased its holdings in shares of Teleflex by 478.1% in the 3rd quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock worth $287,603,000 after purchasing an additional 1,956,811 shares in the last quarter. Norges Bank bought a new position in shares of Teleflex during the fourth quarter valued at $66,076,000. Wolf Hill Capital Management LP purchased a new stake in shares of Teleflex during the fourth quarter valued at $47,405,000. Arrowstreet Capital Limited Partnership boosted its position in shares of Teleflex by 123.9% during the third quarter. Arrowstreet Capital Limited Partnership now owns 660,800 shares of the medical technology company’s stock valued at $80,855,000 after buying an additional 365,663 shares during the last quarter. Finally, Pzena Investment Management LLC increased its holdings in Teleflex by 84.2% in the 1st quarter. Pzena Investment Management LLC now owns 699,125 shares of the medical technology company’s stock worth $83,622,000 after buying an additional 319,660 shares in the last quarter. 95.62% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have issued reports on TFX. Mizuho upped their target price on shares of Teleflex from $140.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, July 15th. Raymond James Financial reiterated an “outperform” rating and issued a $150.00 price target on shares of Teleflex in a research note on Friday, May 8th. Truist Financial reissued a “hold” rating and set a $143.00 price objective (up from $135.00) on shares of Teleflex in a report on Monday, May 11th. BMO Capital Markets assumed coverage on shares of Teleflex in a research report on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price objective on the stock. Finally, Royal Bank Of Canada upgraded shares of Teleflex from a “sector perform” rating to an “outperform” rating and raised their target price for the stock from $135.00 to $155.00 in a report on Friday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $148.00.

Teleflex Stock Performance

TFX opened at $134.33 on Tuesday. The company’s 50 day moving average is $130.57 and its 200 day moving average is $120.56. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. The company has a market cap of $5.95 billion, a price-to-earnings ratio of -5.89, a PEG ratio of 1.00 and a beta of 0.82. Teleflex Incorporated has a 12-month low of $100.18 and a 12-month high of $139.67.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The business had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. During the same period in the prior year, the company earned $1.44 earnings per share. The firm’s revenue was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, equities research analysts predict that Teleflex Incorporated will post 6.7 EPS for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th were paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date was Friday, May 22nd. Teleflex’s dividend payout ratio is -5.96%.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.